• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫对青蒿素有抗药性吗?

Is there any artemisinin resistance in falciparum malaria?

作者信息

Treeprasertsuk S, Viriyavejakul P, Silachamroon U, Vannphan S, Wilairatana P, Looareesuwan S

机构信息

Department of Tropical Medicine, Bangkok, Thailand.

出版信息

Southeast Asian J Trop Med Public Health. 2000 Dec;31(4):825-8.

PMID:11414435
Abstract

We reported two cases of complicated falciparum malaria who had poor response to artesunate with delayed parasite clearance times. They were splenectomized patients who were treated with high doses of artemisinin derivatives. Our cases showed the importance of the spleen in the clearance of malaria parasites and had different clinical outcome, one fatal and one recovery. The host factors, the parasitemia count, the quality of antimalarial chemotherapy and blood level of the antimalarial drugs must be considered in relation to the causes of the delayed clearance of parasitemia.

摘要

我们报告了两例复杂型恶性疟病例,这两名患者对青蒿琥酯反应不佳,疟原虫清除时间延迟。他们是接受高剂量青蒿素衍生物治疗的脾切除患者。我们的病例显示了脾脏在清除疟原虫中的重要性,并且有不同的临床结局,一例死亡,一例康复。必须结合疟原虫血症清除延迟的原因来考虑宿主因素、疟原虫计数、抗疟化疗质量以及抗疟药物的血药浓度。

相似文献

1
Is there any artemisinin resistance in falciparum malaria?恶性疟原虫对青蒿素有抗药性吗?
Southeast Asian J Trop Med Public Health. 2000 Dec;31(4):825-8.
2
Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.口服和静脉注射青蒿琥酯对患有恶性疟原虫疟疾的坦桑尼亚成年男性的疗效以及对青蒿素、氯喹和甲氟喹的体外敏感性
Am J Trop Med Hyg. 1995 Dec;53(6):639-45. doi: 10.4269/ajtmh.1995.53.639.
3
Delayed parasite clearance in a splenectomized patient with falciparum malaria who was treated with artemisinin derivatives.一名接受青蒿素衍生物治疗的恶性疟原虫疟疾脾切除患者的寄生虫清除延迟。
Clin Infect Dis. 1997 Oct;25(4):923-5. doi: 10.1086/597639.
4
Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.青蒿素与抗疟内过氧化物:从草药疗法到靶向化疗
Microbiol Rev. 1996 Jun;60(2):301-15. doi: 10.1128/mr.60.2.301-315.1996.
5
Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia.单纯性恶性疟的治疗:在印度尼西亚伊里安查亚进行的一项随机试验,比较青蒿琥酯加磺胺多辛-乙胺嘧啶与单用磺胺多辛-乙胺嘧啶的疗效。
Am J Trop Med Hyg. 2001 Oct;65(4):309-17. doi: 10.4269/ajtmh.2001.65.309.
6
Frequency of early rising parasitemia in falciparum malaria treated with artemisinin derivatives.青蒿素衍生物治疗恶性疟时早期上升期寄生虫血症的发生率
Southeast Asian J Trop Med Public Health. 2001 Mar;32(1):50-6.
7
Artemisinin antimalarials: mechanisms of action and resistance.青蒿素类抗疟药:作用机制与耐药性
Med Trop (Mars). 1998;58(3 Suppl):13-7.
8
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia.基于青蒿素的联合疗法治疗哥伦比亚非复杂性恶性疟原虫疟疾。
Malar J. 2007 Feb 28;6:25. doi: 10.1186/1475-2875-6-25.
9
[Treatment of children with malaria Plasmodium falciparum with derivatives artemisinin].用青蒿素衍生物治疗儿童恶性疟原虫疟疾
Rev Soc Bras Med Trop. 2003 Mar-Apr;36(2):223-6. doi: 10.1590/s0037-86822003000200005. Epub 2003 Jun 10.
10
Antimalarial drug resistance and combination chemotherapy.抗疟药耐药性与联合化疗
Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):739-49. doi: 10.1098/rstb.1999.0426.

引用本文的文献

1
Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.评价静脉注射青蒿琥酯治疗乌干达儿童重症疟疾的寄生虫清除效果:一项随机对照临床试验。
Malar J. 2018 Oct 30;17(1):400. doi: 10.1186/s12936-018-2552-6.
2
Development of antimalarial drugs and their application in China: a historical review.抗疟药物的发展及其在中国的应用:历史回顾。
Infect Dis Poverty. 2014 Mar 20;3(1):9. doi: 10.1186/2049-9957-3-9.
3
History, dynamics, and public health importance of malaria parasite resistance.
疟原虫耐药性的历史、动态变化及公共卫生重要性。
Clin Microbiol Rev. 2004 Jan;17(1):235-54. doi: 10.1128/CMR.17.1.235-254.2004.